159 related articles for article (PubMed ID: 30073867)
1. Comparison of second- and third-generation immunoassays for detection of anti-cyclic citrullinated peptide antibodies.
Ji M; Hur M; Moon HW; Park M; Yun YM; Lee SH
Scand J Clin Lab Invest; 2018 Oct; 78(6):477-482. PubMed ID: 30073867
[TBL] [Abstract][Full Text] [Related]
2. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis.
Cho J; Pyo JY; Fadriquela A; Uh Y; Lee JH
Clin Rheumatol; 2021 Feb; 40(2):565-573. PubMed ID: 32964298
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies.
Webb T; Lakos G; Swart A; Gürtler I; Favalli EG; Schioppo T; Mahler M
Clin Chim Acta; 2014 Nov; 437():161-7. PubMed ID: 25086283
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.
Martinez-Prat L; Nissen MJ; Lamacchia C; Bentow C; Cesana L; Roux-Lombard P; Gabay C; Mahler M
Front Immunol; 2018; 9():1113. PubMed ID: 29928272
[TBL] [Abstract][Full Text] [Related]
6. Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis.
Swart A; Burlingame RW; Gürtler I; Mahler M
Clin Chim Acta; 2012 Dec; 414():266-72. PubMed ID: 23022338
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.
dos Anjos LM; Pereira IA; d 'Orsi E; Seaman AP; Burlingame RW; Morato EF
Clin Rheumatol; 2009 Feb; 28(2):153-8. PubMed ID: 18795390
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis.
Shidara K; Inoue E; Tanaka E; Hoshi D; Seto Y; Nakajima A; Momohara S; Taniguchi A; Yamanaka H
Rheumatol Int; 2011 May; 31(5):617-22. PubMed ID: 20049446
[TBL] [Abstract][Full Text] [Related]
9. Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis.
Hwang SM; Kim JO; Yoo YM; Shin S; Kim JQ; Park MH; Song EY
Clin Chem Lab Med; 2010 Feb; 48(2):225-30. PubMed ID: 19958210
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.
Santiago M; Baron M; Miyachi K; Fritzler MJ; Abu-Hakima M; Leclercq S; Bell M; Hudson M; Mathieu JP; Taillefer S; Jones N; Docherty P; Khraishi M; Markland J; Pope J; Robinson D; Smith D; Sutton E
Clin Rheumatol; 2008 Jan; 27(1):77-83. PubMed ID: 17570008
[TBL] [Abstract][Full Text] [Related]
11. Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test.
Di Matteo A; Mankia K; Garcia-Montoya L; Sharrack S; Duquenne L; Nam JL; Mahler M; Emery P
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599655
[TBL] [Abstract][Full Text] [Related]
12. Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis.
Lutteri L; Malaise M; Chapelle JP
Clin Chim Acta; 2007; 386(1-2):76-81. PubMed ID: 17826752
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis.
Debaugnies F; Servais G; Badot V; Noubouossie D; Willems D; Corazza F
Scand J Rheumatol; 2013; 42(2):108-14. PubMed ID: 23126558
[TBL] [Abstract][Full Text] [Related]
14. Third-Generation Anti-Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis.
Di Matteo A; Mankia K; Duquenne L; Mahler M; Corscadden D; Mbara K; Garcia-Montoya L; Nam JL; Emery P
Arthritis Rheumatol; 2020 Nov; 72(11):1820-1828. PubMed ID: 32840033
[TBL] [Abstract][Full Text] [Related]
15. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
[TBL] [Abstract][Full Text] [Related]
16. The performance of anti-cyclic citrullinated peptide assays in diagnosing rheumatoid arthritis: a systematic review and meta-analysis.
Mathsson Alm L; Fountain DL; Cadwell KK; Madrigal AM; Gallo G; Poorafshar M
Clin Exp Rheumatol; 2018; 36(1):144-152. PubMed ID: 29185968
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome.
Wu R; Shovman O; Zhang Y; Gilburd B; Zandman-Goddard G; Shoenfeld Y
Clin Rev Allergy Immunol; 2007 Feb; 32(1):47-56. PubMed ID: 17426360
[TBL] [Abstract][Full Text] [Related]
19. The role of anti-cyclic citrullinated peptide (CCP) antibodies in early detection of rheumatoid arthritis: an overview of the INOVA Diagnostics, Inc. QUANTA Lite CCP assays.
Gilliam BE; Moore TL
Expert Opin Med Diagn; 2012 Jul; 6(4):359-69. PubMed ID: 23480744
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis.
Sieghart D; Konrad C; Swiniarski S; Haslacher H; Aletaha D; Steiner G
Front Immunol; 2022; 13():1096866. PubMed ID: 36685579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
